Unknown

Dataset Information

0

LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.


ABSTRACT: While the androgen receptor (AR) might promote renal cell carcinoma (RCC) initiation and progression, the molecular mechanisms involved remain largely unclear. Here, we discovered the novel LncRNA-SARCC, which was suppressed and associated with better prognosis in RCC. Preclinical studies using multiple RCC cells and in vivo mouse model indicated that LncRNA-SARCC could attenuate RCC cell invasion, migration and proliferation in vitro and in vivo. Mechanistically, LncRNA-SARCC bound and destabilized AR protein with an inhibition of AR function, which led to transcriptionally de-repress miR-143-3p expression, thus inhibition of its downstream signals including AKT, MMP-13, K-RAS and P-ERK. In addition, bisulfite sequencing analysis substantiated that LncRNA-SARCC promoter was highly methylated in renal cancer tissues compared with paired non-cancerous renal tissues. Notably, treating with Sunitinib, the multi-targeted receptor tyrosine kinase inhibitor, increased the expression of LncRNA-SARCC, which decreased RCC cells resistance to Sunitinib. Thus, our study presented a road map for targeting this newly identified LncRNA-SARCC and its pathway, which expands potential therapeutic strategies for RCC treatment.

SUBMITTER: Zhai W 

PROVIDER: S-EPMC5563985 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.

Zhai Wei W   Sun Yin Y   Guo Changcheng C   Hu Guanghui G   Wang Mingchao M   Zheng Jiayi J   Lin WanYing W   Huang Qingbo Q   Li Gonghui G   Zheng Junhua J   Chang Chawnshang C  

Cell death and differentiation 20170623 9


While the androgen receptor (AR) might promote renal cell carcinoma (RCC) initiation and progression, the molecular mechanisms involved remain largely unclear. Here, we discovered the novel LncRNA-SARCC, which was suppressed and associated with better prognosis in RCC. Preclinical studies using multiple RCC cells and in vivo mouse model indicated that LncRNA-SARCC could attenuate RCC cell invasion, migration and proliferation in vitro and in vivo. Mechanistically, LncRNA-SARCC bound and destabil  ...[more]

Similar Datasets

| S-EPMC9424293 | biostudies-literature
| S-EPMC4546459 | biostudies-literature
| S-EPMC5528811 | biostudies-other
| S-EPMC5247285 | biostudies-literature
| S-EPMC4887098 | biostudies-literature
| S-EPMC8257744 | biostudies-literature
| S-EPMC5198573 | biostudies-literature
| S-EPMC6592003 | biostudies-literature
| S-EPMC7453500 | biostudies-literature
| S-EPMC5078576 | biostudies-literature